| Scleroderma induced by paclitaxel. | |
| | |
MedLine Citation:
|
PMID: 20446892 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Joanna Vitfell Pedersen; Signe Jensen; Anders Krarup-Hansen; Lene Riis |
Publication Detail:
|
Type: Case Reports; Letter |
Journal Detail:
|
Title: Acta oncologica (Stockholm, Sweden) Volume: 49 ISSN: 1651-226X ISO Abbreviation: Acta Oncol Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-09 Completed Date: 2010-09-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8709065 Medline TA: Acta Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 866-8 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents, Phytogenic
/
administration & dosage,
adverse effects* Female Genetic Predisposition to Disease Humans Middle Aged Ovarian Neoplasms / drug therapy*, pathology Paclitaxel / administration & dosage, adverse effects* Peritoneal Neoplasms / drug therapy*, secondary Scleroderma, Localized / chemically induced*, genetics Sex Factors Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Phytogenic; 33069-62-4/Paclitaxel |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Next Document: Perinatal, postnatal, and maternal outcome parameters of triplet pregnancies according to the planne...